IBEX Technologies, Inc. manufactures and markets enzymes for biomedical use. The firm also specializes in the custom aliquoting, filling, and lyophilization of enzymes in diagnostic disposables for medical devices. Its products include glycobiology enzymes from flavobacterium heparinum, collagen assays, collagen antibodies, and diamine oxidase liquid. The company was founded by Robert A. Heft on April 10, 1972 and is headquartered in Montréal, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Ibex Technologies Inc. market cap is $24.51M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ibex Technologies Inc. 52 week high is $1.10 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ibex Technologies Inc. 52 week low is $0.56 as of November 22, 2026.
Ibex Technologies Inc. stock price today is $1.00.
Ibex Technologies Inc. stock price yesterday was $1.07.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Ibex Technologies Inc.'s P/E ratio is 8.36.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Ibex Technologies Inc. P/B ratio is 2.3009.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Ibex Technologies Inc. 50-day moving average is $1.01.